We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 142.00
Bid: 141.20
Ask: 142.80
Change: 1.00 (0.71%)
Spread: 1.60 (1.133%)
Open: 142.60
High: 145.00
Low: 142.00
Prev. Close: 141.00
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Sep 2020 11:39

RNS Number : 6218Y
Apax Global Alpha Limited
10 September 2020
 

 

(LSE: APAX)

Apax Global Alpha Limited

 

PDMR Dealing

 

This notification is made in accordance with DTR 3.1 of the Disclosure and Transparency Rules and article 19(1) of the Market Abuse Regulations (EU) no. 596/2014 ("MAR").

 

The Company was notified on 09 September 2020 that, Mr Andrew Guille who is a director of Apax Guernsey Managers Limited, has beneficially acquired 10,000 Ordinary Shares. The 10,000 shares were purchased on 09 September 2020 at an average price of £1.6442 per share. These shares will be held through a nominee arrangement. Following the purchase, Mr Andrew Guille owns 48,868 Ordinary Shares, representing less than 1% of the Company's total issued share capital.

 

 

Contact details

 

Investor relations

Lorraine Rees

IR Manager - AGA

Telephone: +44 (0)207 872 6381

Email: Lorraine.Rees@apax.com

Company secretary

Lewis Germain/ Christopher Copperwaite

Company Secretary

Telephone: +44 (0) 1481 749 700

Email: AGA-admin@aztecgroup.co.uk

 

Notes

 

1.

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser"

2.

This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, into or within the United States or to "US persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act")) or into or within Australia, Canada, South Africa or Japan. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of the announcement may be restricted by law in certain jurisdictions.

 

 

 

About Apax Global Alpha Limited

 

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value.

 

The investment policy of the Company is to make Private Equity investments in Apax Funds, and Derived Investments which are investments in equities and debt derived from the insights gained via Apax Partners' Private Equity activities. Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com.

 

About Apax Partners LLP

 

Apax Partners LLP ("Apax Partners") is a leading global private equity advisory firm and over its more than 40-year history, Apax Partners has raised and advised funds with aggregate commitments of over €40 billion. Funds advised by Apax Partners invest in companies across four global sectors of Tech & Telco, Services, Healthcare and Consumer. These funds provide longterm equity financing to build and strengthen worldclass companies. For further information about Apax Partners, please visit www.apax.com. Apax Partners is authorised and regulated by the Financial Conduct Authority in the UK.

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

ANDREW GUILLE

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR - INVESTMENT MANAGER

b)

 

Initial notification /Amendment

 

 

INITIAL

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

APAX GLOBAL ALPHA LIMITED

b)

 

LEI

 

21380031LQE8CU8NU843

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

ORDINARY SHARES

 

 

APAX

b)

 

Nature of the transaction

 

 

PURCHASE

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

£1.6442

10,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

AS IN 4 C) ABOVE

 

 

 

 

 

 

e)

 

Date of the transaction

 

09 September 2020

f)

 

Place of the transaction

 

 

LONDON STOCK EXCHANGE

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGGDCIXBDGGG
Date   Source Headline
5th Mar 20197:00 amRNS2018 Annual Report and Accounts
5th Mar 20197:00 amRNS2018 Final Results
26th Feb 201911:42 amRNSExits from Exact Software and AssuredPartners
29th Jan 20197:00 amRNSApax Funds' Valuations as at 31 December 2018
21st Dec 20181:48 pmRNSDirector/PDMR Shareholding
21st Dec 201812:09 pmRNSInclusion in FTSE 250 Index
19th Dec 20186:30 pmRNSShire
27th Nov 201810:00 amRNSPDMR Dealing - Share Transfers
23rd Nov 20183:07 pmRNSDirector Dealings - Chris Ambler
14th Nov 20187:00 amRNSNotice of Annual Results
7th Nov 20187:00 amRNSNew revolving credit facility
7th Nov 20187:00 amRNSQuarterly results for the period ended 30 Sep 2018
13th Sep 20184:29 pmRNSDirector Dealings - Chris Ambler
5th Sep 20185:12 pmRNSNotice of Quarterly Results 30 Sept 2018
14th Aug 20187:00 amRNS2018 Interim Dividend
14th Aug 20187:00 amRNS2018 Interim Results Highlights
14th Aug 20187:00 amRNS2018 Interim Report and Accounts
31st Jul 20187:00 amRNSApax Funds' Valuations as at 30 June 2018
18th Jul 20183:00 pmRNSHolding(s) in Company
3rd Jul 201810:00 amRNSDirectorate Change
2nd Jul 20183:00 pmRNSDirector Declaration
14th Jun 20187:00 amRNSNotice of Interim Results 2018
6th Jun 20187:00 amRNSAGA Investor Day
23rd May 201810:00 amRNSEU GDPR Data Privacy Notices
3rd May 20187:00 amRNSQuarterly results for 31 March 2018
1st May 20183:04 pmRNSResult of AGM
26th Apr 201812:47 pmRNSDirectorate Change
16th Apr 20187:25 amRNSNotice of Investor Day
19th Mar 20184:46 pmRNSDirector Declaration
19th Mar 201812:00 pmRNSNotice of AGM
14th Mar 20182:45 pmRNSNotice of Quarterly Results Q1 2018
6th Mar 20187:00 amRNS2017 Annual Dividend Announcement
6th Mar 20187:00 amRNSUpdated Key Information Document
6th Mar 20187:00 amRNS2017 Final Results
6th Mar 20187:00 amRNS2017 Annual Report and Accounts
31st Jan 20185:25 pmRNSDirector/PDMR Shareholding
30th Jan 20187:00 amRNSApax Funds' Valuations as at 31 December 2017
4th Jan 20185:09 pmRNSDirectorate Change - Sarah Evans
2nd Jan 201812:00 pmRNSPublication of Key Information Document
15th Dec 20172:06 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSNotice of Annual Results
1st Nov 20177:00 amRNSQ3 2017 Results Highlights
11th Sep 20177:00 amRNS3Q17 Financial Highlights
31st Aug 20172:57 pmRNSAGA's FTSE Index Inclusion
17th Aug 20177:00 amRNS2017 Interim Dividend
17th Aug 20177:00 amRNS2017 Interim Report and Accounts
17th Aug 20177:00 amRNS2017 Interim Results Highlights
1st Aug 20177:00 amRNSApax Funds' Valuations as at 30 June 2017
14th Jul 201710:51 amRNSDirectors' Dealings - Sarah Evans
12th Jul 201710:00 amRNSDirectors' Dealings - Chris Ambler

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.